- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04523610
Telehealth Intervention Program for Older Adults (TIP-OA)
Telehealth Intervention Program for Older Adults (TIP-OA) Struggling With Mental Health/Cognitive Issues
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Social isolation has profound negative impacts on the mental health of older adults (generally those aged ≥60), such as stress, anxiety, cognitive decline, and depression. Depression is the #1 cause of disability worldwide. Prior to the pandemic, mental disorders were affecting >10-15% older adults and more than 1,000,000 Canadians, with an estimated annual cost of $15 billion, which will increase with COVID-19.
There are 4.5 billion people globally in voluntary confinement and practicing social distancing. Older adults are more isolated and face risks to their health: i.e. increased risk for depression, ER visits and hospital admissions. Older isolated individuals are 4-5 times more likely to be rehospitalized. Moreover, older adults with stress, anxiety, and/or depression, have 50% higher healthcare costs and at 2 times increased mortality. Together these factors threaten to further overwhelm a healthcare system already strained from managing the direct morbidity and mortality of COVID-19.
During the pandemic, with an increased burden on health professionals who can be burnt out, reassigned, or infected with COVID-19, engaging lay volunteers may be beneficial to increase capacity. During COVID, many people are currently unable to work/study, are underemployed/unemployed, and able to volunteer. In a low-resource part of India, an in-person lay volunteer intervention was able to improve depression and other mental health symptoms in older adults. However, a systematic review of volunteer interventions in older individuals with mental health found that the evidence-base is limited with small sample sizes, few randomized controlled trials, especially for remote service delivery. Telehealth has been successful in connecting with socially isolated adults. Telehealth can be adopted in areas where healthcare access is limited and has evidence for improving depression and anxiety. However, telehealth programs that use the internet, tablets, smartphones apps or computers may not be accessible to or preferred by older adults; a survey of 500 older adults found that while only 10% used the internet, 77% did own a mobile phone. In the current COVID-19 context, many such interventions are not feasible for rapid implementation due to lack of infrastructure, training, and low rates of digital literacy in older adults. In a telephoning initiative prior to COVID, older isolated adults reported forming satisfying relationships as well as gaining confidence, engaging in the community and being more socially active. Given these limitations and need for immediate support for vulnerable older adults facing isolation during COVID-19, telephone-based support with volunteers is considered a potential fast, inexpensive, scalable, and convenient intervention option requiring further investigation.
The Telehealth Intervention Program (TIP-OA) for older adults was created during the COVID-19 pandemic to support the health of older adults who are isolated or have mental health/cognitive issues. Within the TIP-OA program, volunteers provide friendly phone calls once a week to older adults (age 60+).
The TIP-OA program provides once a week friendly phone calls from trained volunteers to older adults (age 60+), particularly to older adults struggling with mental health/cognitive issues. The clinical program does not provide any kind of treatment to the program user. Rather, the volunteer-based friendly telephone/telehealth calls adopt a simple and proactive communication technique: e.g., calling seniors to inquire about their general wellbeing, giving out information about COVID-19, asking if the seniors need any help or support (e.g. food delivery, medication from their pharmacy), connecting seniors with community organizations offering services (e.g. grocery delivery), or just talking and giving friendly company on the phone to increase a sense of connection. Moreover, program users are given a phone number for queries, comments, or complaints regarding the program or their volunteer. This study evaluates the effectiveness of the clinical service TIP-OA in 1) reducing stress (Perceived Stress Scale), 2) improving the mental health of service users (Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, Fear of COVID-19 Scale), 3) improving mental healthcare utilization (e.g. hospital visits, hospitalizations, and outpatient visits), 4) compare mental health outcomes based on service users baseline risk, as well as 5) understand the experiences of service users, volunteers, and other stakeholders to improve TIP-OA and related future programs.
Using mixed-methods, the impact of the program will be evaluated systematically. The investigators will assess mental health outcomes in 200 older adults at baseline, 4- and 8-weeks (primary study endpoint). In addition, the investigators will perform qualitative analyses focus groups and/or individual semi-structured interviews with older adult participants, volunteers, community partners, and team members. The investigators anticipate that the TIP-OA program will be associated with improvements in stress, anxiety, and depression. If this is indeed the case, the investigators hope to share results with colleagues who could also develop similar programs internationally.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1E4
- Institute of Community and Family Psychiatry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria: Program Users
- TIP-OA Program User
- Aged ≥60 years
- Residing in Montreal
- Speak English or French
- Capable of giving consent (judged by a member of the research team to adequately understand information relevant in making a decision about research participation, and to reasonably appreciate foreseeable consequences of a decision or lack of decision)
Exclusion Criteria: Program Users
- Not capable of giving consent (vetted for this by the clinician team)
Inclusion Criteria: Volunteers
- TIP-OA program volunteer
- Able to speak English or French
Exclusion Criteria: Volunteers
- None
Inclusion Criteria: Stakeholders
- TIP-OA program stakeholder (community partners, program organizers, and clinicians)
- Able to speak English or French
Exclusion Criteria: Stakeholders
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Program Users - Quantitative
The Telehealth Intervention Program (TIP-OA) for older adults was created during the COVID-19 pandemic to support the health of older adults who are isolated or have mental health/cognitive issues.
Within the TIP-OA program, trained volunteers provide friendly phone calls once a week to older adults (age 60+).
200 participants will be recruited for the quantitative component of the study.
|
The volunteer-based weekly Telehealth support primarily provides program users with friendly listening/conversation.
Volunteers will also inquire about their general wellbeing, provide information about COVID-19, and ask if the older adult needs any help or support (e.g.
food delivery, medication from their pharmacy).
|
|
Other: Program Users - Qualitative
Interviews will be conducted with 25 participants regarding their perceptions and experiences in the TIP-OA program.
|
The volunteer-based weekly Telehealth support primarily provides program users with friendly listening/conversation.
Volunteers will also inquire about their general wellbeing, provide information about COVID-19, and ask if the older adult needs any help or support (e.g.
food delivery, medication from their pharmacy).
|
|
Other: Volunteers - Qualitative
15 volunteers taking part in the semi-structured interviews and 16 volunteers participating in the focus groups.
The interviews and focus groups will evaluate their roles, experiences, and challenges volunteering with the TIP-OA program.
|
Participant is a volunteer of the TIP-OA Program
|
|
Other: Stakeholders - Qualitative
18 stakeholders (clinicians, community partners, TIP-OA team members) will participate in focus groups and interviews.
Specifically, 10 clinicians will participate in one focus group and 8 community partners/team members will participate in interviews.
The interviews and focus groups will evaluate their roles, experiences, and challenges volunteering with the TIP-OA program.
|
Participant is a stakeholder of the TIP-OA Program
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived Stress Scale (PSS)
Time Frame: Change from Baseline to 4- and 8-weeks (15 minute assessment)
|
Perceived Stress Scale (PSS) is a 14-item scale used to measure the degree to which life events are experienced and appraised as stressful.
It asks respondents about how often they have felt certain ways in the past month, with responses ranging from 0 (never) to 4 (very often).
|
Change from Baseline to 4- and 8-weeks (15 minute assessment)
|
|
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Change from Baseline to 4- and 8-weeks (15 minute assessment)
|
Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report questionnaire used to diagnose depression and assess symptom severity.
The questionnaire asks individuals how often in the last two weeks they have been bothered by problems like "feeling down, depressed, and hopeless" and "poor appetite or overeating."
Scores for each question include 0 (not at all), 1 (several days), 2 (more than half of the days), and 3 (nearly every day).
|
Change from Baseline to 4- and 8-weeks (15 minute assessment)
|
|
Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: Change from Baseline to 4- and 8-weeks (15 minute assessment)
|
Generalized Anxiety Disorder-7 (GAD-7) is a 7-item scale that measures symptoms of anxiety present in the previous 2 weeks.
Respondents can choose from a score of 0 (not at all sure), 1 (several days), 2 (over half the days), or 3 (nearly every day).
Items include "Not being able to stop or control worrying" and "Being so restless that it's hard to sit still".
|
Change from Baseline to 4- and 8-weeks (15 minute assessment)
|
|
Fear of COVID-19 Scale
Time Frame: Change from Baseline to 4- and 8-weeks (15 minute assessment)
|
Fear of COVID-19 Scale is an 18-item scale measuring individuals' anxiety, fear and concern surrounding the COVID-19 pandemic.
Items include: "Fear that I will be infected" and "Worry if I will be assigned to COVID wards if hospitalized" (34).
|
Change from Baseline to 4- and 8-weeks (15 minute assessment)
|
|
Mental Healthcare Utilization
Time Frame: Assessed in the 8 weeks prior to baseline and during the 8-week follow-up
|
Mental healthcare utilization will be assessed using medical records, including the number of ER visits, hospitalizations, and outpatient visits
|
Assessed in the 8 weeks prior to baseline and during the 8-week follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interviews and Focus Groups with Volunteers
Time Frame: 8-weeks (2 hours)
|
What are the roles, contributions, and challenges of volunteers in identifying the needs of program users and volunteers, providing access to services, and creating appropriate responses to identified needs for the success and efficacy of the program?
|
8-weeks (2 hours)
|
|
Interviews and Focus Groups with Stakeholders
Time Frame: 8-weeks (2 hours)
|
What are the roles, contributions, and challenges of different stakeholders (e.g.
community partners, program organizers, and clinicians) in identifying the needs of program users and volunteers, providing access to services, and creating appropriate responses to identified needs for the success and efficacy of the program?
|
8-weeks (2 hours)
|
|
Interviews with Program Users
Time Frame: 8-weeks (2 hours)
|
What are the experiences and evaluation of the program users about their engagement with the TIP-OA?
Has the program contributed in improving the health of the program users?
|
8-weeks (2 hours)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Soham Rej, MD/MSc, Lady Davis Institute
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TIP-OA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Center for Advanced Facial Plastic SurgeryCompletedStress | Stress, Physiological | Stress Response | Stress (Psychology) | Healthy Adult Female Participants | Stress, Psychologic | Stress Perception | Stress Levels | Stress, Psychological CumulativeUnited States
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Canterbury Christ Church UniversitySussex Partnership NHS Foundation TrustNot yet recruitingOccupational Stress or Workplace StressUnited Kingdom
-
University of PadovaCompletedStress | Stress Disorder | Work Related StressItaly
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
University of North Carolina, Chapel HillWashington University School of Medicine; United States Department of Defense; University of Florida and other collaboratorsRecruitingPost-traumatic Stress Disorder | Acute Stress Disorder | Acute Stress ReactionUnited States
-
K.G. Razumovsky Moscow State University of Technologies...RecruitingStress | Stress (Psychology)Russia
Clinical Trials on Telehealth phone calls
-
University of PennsylvaniaCompleted
-
Centre Hospitalier Universitaire VaudoisCompletedDepression | Anxiety | Aging | Social IsolationSwitzerland
-
Brigham and Women's HospitalCompletedIn Vitro Fertilization | Psychological StressUnited States
-
Ohio State UniversityCompleted
-
The University of Texas Health Science Center,...Completed
-
University of ZurichCompletedChronic Depressive DisorderSwitzerland
-
University Medicine GreifswaldCompletedStaphylococcus Aureus BacteremiaGermany
-
Columbia UniversityNational Institute on Aging (NIA); Brigham and Women's HospitalEnrolling by invitationUncontrolled HypertensionUnited States
-
Stanford UniversityActive, not recruitingParoxysmal Atrial FibrillationUnited States
-
University of Kansas Medical CenterNational Institute on Aging (NIA)CompletedPeripheral Arterial DiseaseUnited States